Financials data is unavailable for this security.
View more
Year on year Medpace Holdings Inc grew revenues 29.17% from 1.46bn to 1.89bn while net income improved 15.26% from 245.37m to 282.81m.
Gross margin | 28.52% |
---|---|
Net profit margin | 16.74% |
Operating margin | 18.79% |
Return on assets | 20.43% |
---|---|
Return on equity | 58.83% |
Return on investment | 45.87% |
More ▼
Cash flow in USDView more
In 2023, Medpace Holdings Inc increased its cash reserves by 768.38%, or 217.18m. The company earned 433.37m from its operations for a Cash Flow Margin of 22.98%. In addition the company used 34.63m on investing activities and also paid 182.64m in financing cash flows.
Cash flow per share | 11.52 |
---|---|
Price/Cash flow per share | 31.11 |
Book value per share | 24.69 |
---|---|
Tangible book value per share | 2.14 |
More ▼
Balance sheet in USDView more
Current ratio | 0.8786 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 21.88%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years) | 35.10 |
---|---|
EPS (TTM) vs TTM 1 year ago | 27.17 |